{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Myasthenia+Gravis+Generalised&page=2", "query": { "condition": "Myasthenia Gravis Generalised", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Myasthenia+Gravis+Generalised&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T12:52:21.615Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04650854", "title": "A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Myasthenia Gravis" ], "interventions": [ { "name": "Rozanolixizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 165, "start_date": "2021-02-03", "completion_date": "2024-01-25", "has_results": true, "last_update_posted_date": "2025-04-18", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 13, "location_summary": "Orange, California • San Francisco, California • Miami, Florida + 9 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04650854" }, { "nct_id": "NCT07294170", "title": "ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myasthenia Gravis", "MG", "gMG", "Generalized Myasthenia Gravis", "Generalized Myasthenia Gravis (gMG)", "AChR-Ab Seropositive Generalized Myasthenia Gravis" ], "interventions": [ { "name": "Efgartigimod IV", "type": "BIOLOGICAL" }, { "name": "Empasiprubart IV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "argenx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2025-12-19", "completion_date": "2028-03-07", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 11, "location_summary": "Carlsbad, California • Miami, Florida • Tampa, Florida + 8 more", "locations": [ { "city": "Carlsbad", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Columbia", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07294170" }, { "nct_id": "NCT04115293", "title": "Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myasthenia Gravis, Generalized" ], "interventions": [ { "name": "zilucoplan (RA101495)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ra Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 174, "start_date": "2019-09-17", "completion_date": "2021-12-30", "has_results": true, "last_update_posted_date": "2025-07-16", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 37, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Los Angeles, California + 33 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04115293" }, { "nct_id": "NCT06799247", "title": "Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myasthaenia Gravis" ], "interventions": [ { "name": "Decartes-08", "type": "BIOLOGICAL" }, { "name": "Placebo Drug", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Cartesian Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2025-05-06", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-03-24", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 23, "location_summary": "Tucson, Arizona • Carlsbad, California • Los Angeles, California + 19 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Carlsbad", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06799247" }, { "nct_id": "NCT07221838", "title": "A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Generalized Myasthenia Gravis", "gMG" ], "interventions": [ { "name": "Oral Corticosteroid Tapering Schedule", "type": "PROCEDURE" }, { "name": "Ravulizumab", "type": "DRUG" }, { "name": "Prednisone/Prednisolone", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2026-03-04", "completion_date": "2027-08-27", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 5, "location_summary": "Chicago, Illinois • Schaumburg, Illinois • Neptune City, New Jersey + 2 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Schaumburg", "state": "Illinois" }, { "city": "Neptune City", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07221838" }, { "nct_id": "NCT03920293", "title": "Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Myasthenia Gravis" ], "interventions": [ { "name": "Ravulizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 175, "start_date": "2019-03-12", "completion_date": "2023-05-25", "has_results": true, "last_update_posted_date": "2024-05-28", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 49, "location_summary": "Phoenix, Arizona • Irvine, California • Loma Linda, California + 43 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03920293" }, { "nct_id": "NCT04833894", "title": "Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Generalized Myasthenia Gravis" ], "interventions": [ { "name": "Efgartigimod IV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "argenx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 12, "start_date": "2021-10-26", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-02-18", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 3, "location_summary": "Chicago, Illinois • Chapel Hill, North Carolina • Charlottesville, Virginia", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04833894" }, { "nct_id": "NCT05644561", "title": "Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Myasthenia Gravis", "gMG" ], "interventions": [ { "name": "Ravulizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 12, "start_date": "2023-06-24", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 4, "location_summary": "Los Angeles, California • Boston, Massachusetts • Chapel Hill, North Carolina + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05644561" }, { "nct_id": "NCT04159805", "title": "A Study of TAK-079 in People With Generalized Myasthenia Gravis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myasthenia Gravis" ], "interventions": [ { "name": "TAK-079", "type": "DRUG" }, { "name": "TAK-079 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2020-01-14", "completion_date": "2022-07-12", "has_results": true, "last_update_posted_date": "2023-06-02", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 27, "location_summary": "Tucson, Arizona • Palo Alto, California • Sacramento, California + 21 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04159805" }, { "nct_id": "NCT04224506", "title": "A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Myasthenia Gravis", "Myasthenia Gravis, Generalized" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "ProgenaBiome", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": "2020-03-02", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-07-24T12:52:21.615Z", "location_count": 1, "location_summary": "Ventura, California", "locations": [ { "city": "Ventura", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04224506" } ] }